
    
      This research study will compare the visual outcomes between a group of patients who are
      treated with monthly injections of Ranibizumab 0.3 mg and two groups of patients who are
      treated with the "Treat and Extend" regimen. One of the "Treat and Extend" groups will also
      receive laser therapy to determine if this has any additional beneficial effects.
    
  